{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "The present study was designed to evaluate the effects of preoperative Lugol solution on thyroid vascularization and surgical morbidity in patients with Graves\u2019 disease undergoing total thyroidectomy."
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Fifty-six patients undergoing total thyroidectomy for Graves\u2019 disease were randomly assigned to receive 7 days of Lugol treatment (Lugol+ group, 29) or no Lugol treatment (LS\u2013 group, 27) before surgery in this single-centre and single-blinded trial."
      },
      "Participants": {
        "score": 2,
        "evidence": "Fifty-six patients undergoing total thyroidectomy for Graves\u2019 disease were randomly assigned to receive 7 days of Lugol treatment (Lugol+ group, 29) or no Lugol treatment (LS\u2013 group, 27) before surgery in this single-centre and single-blinded trial."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Fifty-six patients undergoing total thyroidectomy for Graves\u2019 disease were randomly assigned to receive 7 days of Lugol treatment (Lugol+ group, 29) or no Lugol treatment (LS\u2013 group, 27) before surgery."
      },
      "Objective": {
        "score": 1,
        "evidence": "The present study was designed to evaluate the effects of preoperative Lugol solution on thyroid vascularization and surgical morbidity in patients with Graves\u2019 disease undergoing total thyroidectomy."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was intraoperative and postoperative blood loss."
      },
      "Randomisation_Allocation": {
        "score": 1,
        "evidence": "Fifty-six patients undergoing total thyroidectomy for Graves\u2019 disease were randomly assigned to receive 7 days of Lugol treatment."
      },
      "Blinding": {
        "score": 1,
        "evidence": "single-centre and single-blinded trial."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "Fifty-six patients undergoing total thyroidectomy for Graves\u2019 disease were randomly assigned."
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "No differences between T0 and T1 were found for ultrasonographic vascularization in either group, nor did the histological findings differ."
      },
      "Harms": {
        "score": 1,
        "evidence": "No differences between T0 and T1 were found for ultrasonographic vascularization in either group, nor did the histological findings differ."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Registration number: NCT05784792 ( https://www.clinicaltrials.gov )."
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 16,
    "max_score": 25
  },
  "model": "gpt-4o"
}